| William Chun, RPH | |
|
635 S Melrose Dr, Vista, CA 92081-6622 | |
| (760) 643-3904 | |
| (760) 732-3410 |
| Full Name | William Chun |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 635 S Melrose Dr, Vista, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093187460 | NPI | - | NPPES |
| 30452 | Other | CA | CALIFORNIA BOARD OF PHARMACY LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 30452 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Chun, RPH 635 S Melrose Dr, Vista, CA 92081-6622 Ph: (760) 643-3904 | William Chun, RPH 635 S Melrose Dr, Vista, CA 92081-6622 Ph: (760) 643-3904 |
News Archive
Never underestimate the power of Mom when it comes to influencing children's health. University of Cincinnati research explains how motherly influence could be even more effective when supported by Web-based parent education programs.
Two proteins conspire to promote a lethal neurological disease, according to a study published online this week in the Journal of Experimental Medicine.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
Xcorporeal, Inc. (the "Company" or "Xcorporeal") announced today that on December 14, 2009 it signed an asset purchase agreement (the "Purchase Agreement") with National Quality Care, Inc. ("NQCI", and together with the Company, the "Sellers"), and Fresenius USA, Inc. (the "Purchaser"), a Massachusetts corporation and a wholly owned subsidiary of Fresenius Medical Care Holdings, Inc., to sell substantially all of the assets of the Sellers to the Purchaser for an aggregate cash purchase price of $8,000,000 (the "Purchase Price") and certain additional royalty payment rights.
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
› Verified 9 days ago
Mrs. Tam Minh Vo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1751 University Dr, T-1040, Vista, CA 92083 Phone: 760-208-6000 Fax: 760-208-6000 | |
Chiara Sandri, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1363 E Vista Way, Vista, CA 92084 Phone: 760-726-1909 | |
Dr. Sarah Widner, PHARM.D., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 883 S Santa Fe Ave, Vista, CA 92083 Phone: 760-630-2134 | |
Timothy Wong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 802 S Santa Fe Ave, Vista, CA 92084 Phone: 760-724-3116 | |
Aimee Nganso, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 635 S Melrose Dr, Vista, CA 92081 Phone: 760-643-3904 | |
Cheng-hsien Jim Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 635 S Melrose Dr, Vista, CA 92081 Phone: 760-643-3904 | |
Kerri Duren, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 130 Cedar Rd, Vista, CA 92083 Phone: 760-630-8806 Fax: 760-630-2406 |